Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry: bridging between the PARADIGM-HF trial, ESC Guidelines and real-world
25 May 2019 (00:00 - 00:00)
Organised by:
About the speaker
Attikon University Hospital, Athens (Greece)
10 More presentations in this session
Professor K. Sliwa (Cape Town, ZA)
Access the full session
The Event
Heart Failure 2019
25 May - 28 May 2019
You may be interested in
Congress Presentation
Congress Presentation
